New York State Common Retirement Fund Sells 5,100 Shares of The Clorox Company (NYSE:CLX)

New York State Common Retirement Fund decreased its holdings in shares of The Clorox Company (NYSE:CLX) by 6.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 71,887 shares of the company’s stock after selling 5,100 shares during the period. New York State Common Retirement Fund’s holdings in Clorox were worth $11,675,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Brooklyn Investment Group boosted its holdings in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new position in shares of Clorox during the 3rd quarter valued at $27,000. Continuum Advisory LLC boosted its stake in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares in the last quarter. Asset Planning Inc acquired a new stake in Clorox in the fourth quarter worth $32,000. Finally, Catalyst Capital Advisors LLC bought a new stake in Clorox in the third quarter valued at $54,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on CLX shares. Barclays raised their target price on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. Evercore ISI boosted their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Wells Fargo & Company increased their target price on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. DA Davidson decreased their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $158.21.

Clorox Trading Down 1.7 %

NYSE:CLX opened at $154.52 on Tuesday. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The firm has a 50-day moving average price of $157.53 and a two-hundred day moving average price of $160.03. The firm has a market cap of $19.03 billion, a price-to-earnings ratio of 42.22, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company earned $2.16 EPS. On average, equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.